Obesity Series Live

CME Presentations

ObesityWeek 2017 Highlights



  • Deborah Bade Horn, DO, MPH, MFOMA

    Deborah Bade Horn, DO, MPH, MFOMA

    Deborah Bade Horn, DO, MPH, MFOMA

    Chairman, Board of Trustees, Obesity Medicine Association

    Deborah Bade Horn, DO, MPH, MFOMA, is the medical director for the Center for Obesity Medicine and Metabolic Performance, clinical assistant professor at the University of Texas McGovern Medical School, and program director for the UT COMMP Fellowship in Clinical Obesity Medicine and Metabolism. She is a diplomate of the American Board of Obesity Medicine and currently serves as the president of the Obesity Medicine Association. She regularly presents in a variety of educational formats and venues about physical activity, obesity, and weight-related comorbidities. Dr Horn received her medical degree from Kirksville College of Osteopathic Medicine in Missouri, and holds two master’s degrees–one in exercise physiology, and another in public health and physical activity.
  • Nadia B. Pietrzykowska, MD, FACP

    Nadia B. Pietrzykowska, MD, FACP

    Nadia B. Pietrzykowska, MD, FACP

    President and Medical Director

    Nadia B. Pietrzykowska, MD, FACP, is a board-certified obesity medicine specialist and physician nutrition specialist. She currently practices in Ewing, New Jersey, and is the president and medical director of “Weight & Life MD”. Dr Pietrzykowska graduated from Warsaw Medical School in Poland. After moving to the United States, she was a postdoctoral research associate at the University of Massachusetts Medical School in Worcester. She completed an internal medicine residency at Capital Health in Trenton, New Jersey, and completed a fellowship in obesity medicine and nutrition at Geisinger Medical Center in Danville, Pennsylvania. Dr Pietrzykowska is actively involved with the Obesity Action Coalition as a member of their education committee and regularly writes for their magazine.
  • Sean Hashmi, MD, MS, FASN

    Sean Hashmi, MD, MS, FASN

    Sean Hashmi, MD, MS, FASN

    Assistant Area Medical Director

    Sean Hashmi, MD, MS, FASN, is the assistant area medical director at Kaiser Permanente, Woodland Hills in California, as well as the Southern California regional lead for Adult Weight Management. He currently serves as the secretary/treasurer of the Clinical Management of Obesity Section of The Obesity Society. Dr Hashmi graduated from the University of California, San Diego Medical School, and completed his residency in internal medicine at UCLA-Olive View Medical Center followed by a fellowship in nephrology at the University of California, Los Angeles. He has earned several teaching awards, and routinely mentors the Woodland Hills Family Medicine Residency Program. Dr Hashmi is an author of several academic presentations focusing in the nutrition, obesity, and kidney disease.

CME Information

Online Symposia Highlights from TOS's 2017 Annual Meeting at ObesityWeek: Examining Successful Obesity Practice Models in a Variety of Delivery Settings


At the conclusion of this activity, participants will be able to:

  • Incorporate knowledge about coding for reimbursement into the clinical practice of health care providers to support their ability to treat the underlying disease of overweight and obesity
  • Incorporate knowledge about best practices to develop and run effective clinics that treat overweight and obesity


This activity is supported by an educational grant from Novo Nordisk.



Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and PlatformQ Health Education, LLC. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statements

Enduring Material

Boston University School of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Overview

Most recent national estimates suggest that 36% of adults and 17% of youth in the United States are considered obese. Further, comorbidities secondary to obesity contribute to a significant decrease in patients’ quality of life and increase in economic burden. With multiple possible etiologies, clinicians are continuously challenged to provide effective approaches in obesity and overweight management. Primary care physicians play an important role in the management of chronic illnesses especially obesity. However, they feel unequipped and inadequately supported to address the complexity of an efficient and coordinated management of overweight and obesity clinics. Furthermore, they ascribe the inability to lose weight to a lack of patient motivation and adherence to weight management therapies, particularly those involving lifestyle changes in diet and exercise. The Centers for Medicaid and Medicare Services (CMS) reimburses for obesity intensive behavioral therapy rendered in the primary care setting, but challenges in reimbursement remain beyond the 6-month contingency of 3-kg weight loss. Furthermore, several societies and organizations, including, TOS, the American Heart Association and the American College of Cardiology, recommend that physicians screen for overweight and obesity in their practice and provide intensive behavioral counseling. Despite the reimbursement incentive and recommendation, the rates of screening and counseling remain low in these settings. Multidisciplinary clinic models, documentation/coding approaches, and electronic health record protocol implementations are all potential solutions and should be made available and accessible to clinicians. Clinicians would benefit from education by experts from obesity clinics in various settings with discussions focused on effective practice models for overweight and obesity clinics, recommendations on appropriate coding for reimbursement with suitable documentation, and insights on implementing an electronic health record that supports an obesity management protocol. Education on practical approaches to run an effective obesity medicine clinic/practice will enable primary care and community clinicians to be more inclined to impact the lives of their patients and slow the epidemic.

Intended Audience

The intended audience for this activity consists of health care providers of people who may be obese and need pharmacotherapeutic interventions and includes the following groups:
The target audience consists of physicians (general medicine, internal medicine, family practice), endocrinologists, surgeons, pediatricians, dietitians, psychologists, physician assistants, nurses, nurse practitioners, rehabilitation/exercise therapists, physical/occupational therapists, clinicians, nutritionists, trainees, basic and clinical research scientists, and social workers

  • Providers: Physicians (primary care and those of relevant specialties such as endocrinology or cardiology), nurse practitioners, physician assistants
  • Lifestyle specialists: Mental health providers, dietitians/nutritionists, exercise professionals

Date of Release/Expiration

Enduring Material

The enduring material will be available from November 30, 2017 – May 30, 2018.

Estimated Time to Complete

This activity consists of 3 30-minute modules, which should take approximately 1.5 hours to complete.


Nadia B. Pietrzykowska, MD, FACP
President and Medical Director
Weight & Life MD
Ewing, New Jersey

Deborah Bade Horn, DO, MPH, MFOMA
Medical Director, Clinical Assistant Professor
University of Texas McGovern Medical School
Houston, Texas

Sean Hashmi, MD, MS, FASN
Assistant Area Medical Director
Kaiser Permanente
Woodland Hills, California

CME Course Advisor
Caroline Apovian, MD
Professor of Medicine and Pediatrics, Section of Endocrinology, Diabetes, and Nutrition
Boston University School of Medicine
Director, Nutrition and Weight Management Center
Boston Medical Center
Boston, Massachusetts

Disclosure Policy

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

Financial Disclosures


Nadia B. Pietrzykowska, MD, FACP, has no relevant financial relationships to disclose.

Deborah Bade Horn, DO, MPH, MFOMA, Advisory Boards and Speakers Bureau relationship with Novo, Nordisk (pharmaceuticals); Advisory Boards and Speakers Bureau relationship with Orexigen (pharmaceuticals); Advisory Board relationship with Optifast (pharmaceuticals)

Sean Hashmi, MD, MS, FASN, has no relevant financial relationships to disclose.

Boston University School of Medicine CME course Advisor

Caroline Apovian, MD, Nutrisystem: Corporate Advisory Board (Self) Food; Zafgen: Corporate Advisory Board (Self) Pharmaceuticals; Sanofi-Aventis: Corporate Advisory Board (Self) Pharmaceuticals; Orexigen: Corporate Advisory Board (Self) Pharmaceuticals; NovoNordisk: Corporate Advisory Board (Self) Pharmaceuticals; GI Dynamics: Corporate Advisory Board (Self) Medical Device; GI Dynamics: Contracted Research (Self) Medical Device; Scientific Intake: Corporate Advisory Board (Self) Medical Device; Gelesis: Corporate Advisory Board (Self) Medical Device; Gelesis: Contracted Research (Self) Medical Device; Science-Smart LLC: Stock Options (including future) (Self) Food/Supplement; Energesis: Contracted Research (Self) Biotech

Boston University School of Medicine

Naomi Moeller, Senior Program Manager, has no relevant financial relationships to disclose.

The Obesity Society CME Oversight Reviewer

Van S. Hubbard, MD, PhD, has no relevant financial relationships to disclose

The Obesity Society Annual Program Committee - Planners

Jaime Almandoz, MD, has no relevant financial relationships to disclose

Lori M. Zeltser, PhD, has no relevant financial relationships to disclose

Sharon J. Herring, MD, has no relevant financial relationships to disclose

PlatformQ Health Education, LLC

Karen Greb-Murphy, Senior Program Manager, has no relevant financial relationships to disclose.

Method of Participation

There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. It is estimated that this module will take approximately 1.5 hours to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the posttest.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

DISCLAIMERS (if applicable):


The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Boston University School of Medicine, ObesitySeriesLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Contact Information

Please send content inquiries to: cme@joslin.harvard.edu

Please send CME inquiries to: cme@bu.edu

For issues with your CME Certificate, please contact ObesitySeriesLive at 877-394-1306 or at Support@ObesitySeriesLive.com.